140 related articles for article (PubMed ID: 3944748)
1. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
Macfarlane PI; Miller V; Wells F; Richards B
J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders.
Shine B; Berghouse L; Jones JE; Landon J
Clin Chim Acta; 1985 May; 148(2):105-9. PubMed ID: 3995779
[TBL] [Abstract][Full Text] [Related]
3. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
Vucelić B; Milicić D; Krznarić Z; Korać B; Sentić M; Hadzić N; Stavljenić A; Cvorisćec D
Acta Med Austriaca; 1991; 18(4):100-5. PubMed ID: 1722373
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Erythrocyte Sedimentation Rate and C-Reactive Protein With Pediatric Inflammatory Bowel Disease Activity.
Alper A; Zhang L; Pashankar DS
J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):e25-e27. PubMed ID: 27741061
[TBL] [Abstract][Full Text] [Related]
5. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
Philipsen EK; Bondesen S; Andersen J; Larsen S
Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
[TBL] [Abstract][Full Text] [Related]
9. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
10. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis.
Moran A; Jones A; Asquith P
Scand J Gastroenterol; 1995 Apr; 30(4):356-60. PubMed ID: 7610352
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis.
Turner D; Mack DR; Hyams J; LeLeiko N; Otley A; Markowitz J; Kasirer Y; Muise A; Seow CH; Silverberg MS; Crandall W; Griffiths AM
J Crohns Colitis; 2011 Oct; 5(5):423-9. PubMed ID: 21939916
[TBL] [Abstract][Full Text] [Related]
12. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
Miranda-García P; Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
14. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
[TBL] [Abstract][Full Text] [Related]
15. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease.
Takaki Y; Mizuochi T; Eda K; Ishihara J; Yamashita Y
Pediatr Int; 2019 Jul; 61(7):720-725. PubMed ID: 31102555
[TBL] [Abstract][Full Text] [Related]
16. Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis.
Descos L; André F; André C; Gillon J; Landais P; Fermanian J
Digestion; 1983; 28(2):148-52. PubMed ID: 6653927
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
[TBL] [Abstract][Full Text] [Related]
18. Plasma viscosity in inflammatory bowel disease.
Lobo AJ; Jones SC; Juby LD; Axon AT
J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral indices of disease activity in inflammatory bowel disease.
Koldkjaer O; Klitgaard NA; Schmidt KG
Digestion; 1978; 17(5):387-95. PubMed ID: 680416
[TBL] [Abstract][Full Text] [Related]
20. Role of serology and routine laboratory tests in childhood inflammatory bowel disease.
Khan K; Schwarzenberg SJ; Sharp H; Greenwood D; Weisdorf-Schindele S
Inflamm Bowel Dis; 2002 Sep; 8(5):325-9. PubMed ID: 12479647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]